$17.98
Open
$0.23(1.30%)

Today

About

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. The company is headquartered in Nova Lima, Minas Gerais. The company went IPO on 2019-07-19. The firm is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The firm's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The firm's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.
Country

BR

CEO

Mr. Virgilio Gibbon

IPO date

2019

Employees

5,260

ISIN

KYG011251066

Key stats

Open

$17.47

Volume

617.45K

Market cap

$1.61B

Prev. close

$17.76

Impl / hst vl

-

Open interest

$0.00

$0.00

Day’s Range

$0.00

$14.52

52W Range

$19.90

Valuation

88
Valuation score
Strongly undervalued
P/E
12.90
P/S
2.55
P/B
1.99
Current ratio
1.42
Debt / Equity
0.47
ROE
16.23%
Gross margin
69.82%
Income growth
68.08%
FCF growth
95.38

Apr

4

Dividends

The last payment date was Apr 4, 2025

Div. per Share

$0.23

Div. Yield

7.64%

Payout Ratio

-

Div. Growth YoY

-

Analysts estimates

Consensus rating
Hold

The average rating from top 10 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$19.89
The top 10 analysts forecasts that 12-month price may increase by 10.62%, with a low of $16.16 and a high of $25.20
$16.16
Low
$19.89
Avg
$25.20
High
Current price

Earnings

Q1 ‘25 revenue
$167.98M
Q1 ‘25 net income
$45.21M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.35
Actual EPS
Estimate EPS